Background Image
Previous Page  151 / 156 Next Page
Show Menu
Previous Page 151 / 156 Next Page
Page Background





Taylor D, Galan V, Weinstein SM, Reyes E, Pupo-Araya AR, Rauck R. Fentanyl pectin nasal

spray in breakthrough cancer pain. J Support Oncol 2010; 8(4): 184-190.


Tei Y, Morita T, Nakaho T, Takigawa C, Higuchi A, Suga A, Tajima T, Ikenaga M, Higuchi H,

Shimoyama N, Fujimoto M.Treatment efficacy of neural blockade in specialized palliative

care services in Japan: a multicenter audit survey. J Pain Symptom Manage 2008; 36(5):



Tessaro L, Bandieri E, Costa G, Fornasier G, Iorno V, Pizza C, Pastacaldi G, Micheletto

G. Use of oxycodone controlled-release immediately after NSAIDs: a new approach to

obtain good pain control. Eur Rev Med Pharmacol Sci 2010; 14(2): 113-121.


Tester W, Ackler J, Tijani L, Leighton J. Phase I/II study of weekly docetaxel and vinblastine

in the treatment of metastatic hormone-refractory prostate carcinoma. Cancer J 2006;

12(4): 299-304.


Theiler R, Alon E, Brugger S, Ljutow A, Mietzsch T, Müller D, Ott A, Rimle M, Zemp

A,Urwyler A. Evaluation of a standardized internet-based and telephone-based patient

monitoring system for pain therapy with transdermal fentanyl. Clin J Pain 2007; 23(9):



Townsend CO, Kerkvliet JL, Bruce BK, Rome JD, Hooten WM, Luedtke CA, Hodgson JE. A

longitudinal study of the efficacy of a comprehensive pain rehabilitation program with

opioid withdrawal: comparison of treatment outcomes based on opioid use status at

admission. Pain 2008; 140(1): 177-189.


Tsay SL, Chen HL, Chen SC, Lin HR, Lin KC. Effects of reflexotherapy on acute postope-

rative pain and anxiety among patients with digestive cancer. Cancer Nurs 2008; 31(2):



Tschirner M, Ritzdorf I, Brunjes R. [Post marketing surveillance study with an analgesic

(transdermal buprenorphine patch) in patients with moderate to severe chronic pain].

MMW Fortschr Med 2008; 150 Suppl 3: 142-148.


Ture H, Sayin M, Karlikaya G, Bingol CA, Aykac B, Ture U. The analgesic effect of gaba-

pentin as a prophylactic anticonvulsant drug on postcraniotomy pain: a prospective

randomized study. Anesth Analg 2009; 109(5): 1625-1631.


Ueberall MA, Mueller-Schwefe GH. Sublingual fentanyl orally disintegrating tablet in daily

practice: efficacy, safety and tolerability in patients with breakthrough cancer pain. Curr

Med Res Opin 2011; 27(7): 1385-1394.


Valeberg BT, Miaskowski C, Hanestad BR, Bjordal K, Moum T, Rustoen T. Prevalence rates

for and predictors of self-reported adherence of oncology outpatients with analgesic

medications. Clin J Pain 2008; 24(7): 627-636.


Valjus M, Ahonen J, Jokela R, Korttila K. Response Entropy is not more sensitive than

State Entropy in distinguishing the use of esmolol instead of remifentanil in patients

undergoing gynaecological laparoscopy. Acta Anaesthesiol Scand 2006; 50(1): 32-39.


van der Linden YM, Steenland E, van Houwelingen HC, Post WJ, Oei B, Marijnen CA, Leer

JW; Dutch Bone Metastasis Study Group. Patients with a favourable prognosis are equally

palliated with single and multiple fraction radiotherapy: results on survival in the Dutch

Bone Metastasis Study. Radiother Oncol 2006; 78(3): 245-253.